AriBio, Co.
Latest round
- Series B
Last raised
- Nov 2014
Total raised
- $3.5M
Investors
- 2
About AriBio, Co.
Based in Seongnam, South Korea, and founded in 2010, AriBio develops an artificial intelligence-powered, reserve-engineered, and integrated drug development (AIRDD) platform for neurodegenerative diseases. The business offers an AIRDD multi-mechanism medication for neurodegenerative disorders like Alzheimer's, which are caused by a combination of hereditary, environmental, and psychological factors. The platform uses AI to engage drugs across various targets and mechanisms in a large chemical database. The company's solutions for Alzheimer's disease, prodromal illness, and rent syndrome are in the enabling stage, while moderate cognitive impairment and dementia with lewy bodies are in phase 2.
Who invested in AriBio, Co.
2 investors across 1 round
See all investors in AriBio, Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 14, 2014
Amount
$3.5M
Investors
Questions about AriBio, Co.
Who invested in AriBio, Co.?
AriBio, Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AriBio, Co. raised?
AriBio, Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AriBio, Co. last raise money?
AriBio, Co.'s most recent round on record is a Series B, in Nov 2014.
What does AriBio, Co. do?
Based in Seongnam, South Korea, and founded in 2010, AriBio develops an artificial intelligence-powered, reserve-engineered, and integrated drug development (AIRDD) platform for neurodegenerative diseases.
Where is AriBio, Co. headquartered?
AriBio, Co. is headquartered in Seongnam, South Korea.
Which VCs invest in companies like AriBio, Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at AriBio, Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like AriBio, Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.